Cargando…
The Treatment with Interleukin 17 Inhibitors and Immune-Mediated Inflammatory Diseases
IL-17 inhibitors (IL-17i) are medicines used to treat dermatological and rheumatic diseases They belong to a class of medicines called biological disease-modifying anti-rheumatic drugs (bDMARDs). This class of drugs has had a major impact on the therapy of autoimmune diseases, being much safer and m...
Autores principales: | Țiburcă, Laura, Bembea, Marius, Zaha, Dana Carmen, Jurca, Alexandru Daniel, Vesa, Cosmin Mihai, Rațiu, Ioana Adela, Jurca, Claudia Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164043/ https://www.ncbi.nlm.nih.gov/pubmed/35678656 http://dx.doi.org/10.3390/cimb44050127 |
Ejemplares similares
-
Effects of Burosumab Treatment on Two Siblings with X-Linked Hypophosphatemia. Case Report and Literature Review
por: Jurca, Claudia Maria, et al.
Publicado: (2022) -
Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review
por: Jurca, Claudia Maria, et al.
Publicado: (2023) -
Genetics of congenital solid tumors
por: Jurcă, Maria Claudia, et al.
Publicado: (2020) -
Changes in skeletal dysplasia nosology
por: Jurcă, Maria Claudia, et al.
Publicado: (2021) -
Cardiofaciocutaneous syndrome – a longitudinal study of a case over 33 years: case report and review of the literature
por: Jurcă, Maria Claudia, et al.
Publicado: (2021)